Literature DB >> 1970350

Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells.

W T Lee1, X M Yin, E S Vitetta.   

Abstract

CD4+ murine T cell clones, TH1 and TH2, can be distinguished by both functional responses and by their patterns of lymphokine secretion. Recently, a mAb, 23G2, which reacts with a subset of CD45 molecules (CD45R), has been reported to bind differentially to clones of TH1 and TH2 cells. In the present study, normal splenic T cells were analyzed for differences in 23G2-reactivity and were separated into two populations based on their density of CD45R (CD45Rhi and CD45Rlo). The CD45Rhi cells secrete more IL-2 than IL-4 after stimulation in vitro; the reverse is true for the CD45Rlo cells. Because neither population secretes only IL-2 or IL-4, we were unable to classify cells as TH1 or TH2. In vivo and in vitro analyses of the CD45Rhi and CD45Rlo cells suggest a lineage relationship between the two subsets that correlates with the degree of Ag exposure and the state of maturation of the mice. In newborn mice and mice raised under sterile conditions, splenic CD4+ T cells are predominantly CD45Rhi. Under conditions of increased antigenic exposure and maturation of the mice, CD45Rlo cells develop; after long term priming in vivo, the majority of specific Ag-reactive cells are CD45Rlo. Adoptive transfer studies using BALB/c nu/nu recipients demonstrate that CD45Rhi cells become CD45Rlo cells and that the recall response (IgG) to specific Ag is mediated by CD45Rlo cells. Taken together, these data indicate that the level of expression of CD45R on CD4+ T cells distinguishes virgin (CD45Rhi) from primed/memory (CD45Rlo) T cells in normal mice.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970350

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  58 in total

Review 1.  The immune system in the elderly: II. Specific cellular immunity.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; V Martorelli; D Quaglino
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Qualitative differences between naïve and memory T cells.

Authors:  Marion Berard; David F Tough
Journal:  Immunology       Date:  2002-06       Impact factor: 7.397

3.  Anergy in CD4 memory T lymphocytes. II. Abrogation of TCR-induced formation of membrane signaling complexes.

Authors:  William T Lee; Aparna Prasad; Andrew R O Watson
Journal:  Cell Immunol       Date:  2012-05-19       Impact factor: 4.868

4.  Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms.

Authors:  M Plebanski; M Saunders; S S Burtles; S Crowe; D C Hooper
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

5.  Pattern of lectin binding to murine T lymphocytes.

Authors:  R A Sowalsky; B S Fox
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

Review 6.  CD45 isoform expression: implications for recirculation of naive and memory cells.

Authors:  P C Beverley
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

7.  CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivo.

Authors:  Z Wang; J D Davies
Journal:  Int Immunopharmacol       Date:  2006-11-28       Impact factor: 4.932

8.  A novel role for CD4+ T cells in the control of cachexia.

Authors:  Zhuangzhi Wang; Chunfang Zhao; Rosa Moya; Joanna D Davies
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

9.  CD4(+) CD44(v.low) cells are unique peripheral precursors that are distinct from recent thymic emigrants and stem cell-like memory cells.

Authors:  Chunfang Zhao; Idania Marrero; Aditi Narsale; Rosita Moya; Joanna D Davies
Journal:  Cell Immunol       Date:  2015-04-17       Impact factor: 4.868

10.  Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

Authors:  Santiago Zelenay; Thiago Lopes-Carvalho; Iris Caramalho; Maria Francisca Moraes-Fontes; Manuel Rebelo; Jocelyne Demengeot
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.